Overview

Attendees of this symposium will gain an appreciation of the latest advances in non-small cell lung cancer (NSCLC), including updates on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), and the importance of EGFR mutation testing and broader molecular profiling to tailor therapy and improve patient outcomes. Expert faculty will review evolving treatment paradigms in EGFR-mutated NSCLC, explore molecular profiling incorporating newer testing modalities, examine how treatments align to individual patient characteristics, and discuss effective strategies to improve communication between clinician and patient/caregiver to reduce adverse effects and improve adherence. To better understand the patient’s perspective of living with NSCLC, this symposium will also incorporate an interactive panel discussion with founding members of the EGFR Resisters lung cancer patient advocacy group. Incorporating the lung cancer patient’s voice into this educational activity will provide oncology nurses with insight regarding the patient’s perspective on their disease, including the stigma often associated with lung cancer, effective communication strategies between the patient and clinician, coping mechanisms, support groups and other resources available to patients.

View All Speakers

Speakers

Jill Feldman, MA


Founding Member, EGFR Resisters EGFR+ NSCLC since 2009 Deerfield, Illinois
View Full Bio

Zofia Piotrowska, MD, MHS


Instructor of Medicine Harvard Medical School Assistant in Medicine Massachusetts General Hospital Boston, Massachusetts
View Full Bio

Ivy Elkins, MBA


Founding Member, EGFR Resisters EGFR+ NSCLC since 2014 Buffalo Grove, Illinois
View Full Bio

Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP


Adult Oncology Nurse Practitioner for Thoracic Malignancies Abramson Cancer Center University of Pennsylvania Medical Center Advanced Senior Lecturer University of Pennsylvania School of Nursing Philadelphia, Pennsylvania
View Full Bio

Accreditation

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing (ANCC)

CEC designates this live educational activity for 1.5 nursing contact hours.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity. 

Upon completion of a CNE request form, statements of credit will be issued to nurses within 30 business days. 

 

ONCC/ILNA Certification Information

The program content has been reveiwed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. OCN®, AOCNP®, CBCN®, CPHON®, BMTCN®, and AOCNS® nurses may apply 1.5 points in Coordination of Care, Diagnosis and Staging, Professional Practice, Psychosocial, Scientific Basis for Practice, Symptom Management, and Treatment categories. 

Disclaimer: ONCC review is only for designating content to be used for recertification points and is not for CNE accreditation. CNE programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing CE to be used for recertification by ONCC. If the CNE provider fails to obtain formal approval to award contact hours by an acceptable accreditating/approval body, no information related to ONCC recertification may be used in relation to the program. 

Acknowledgement

This activity is presented by Creative Educational Concepts, Inc.

This activity is supported through an independent educational grant from AstraZeneca.